Quarterly Revenue Up 24% Year over Year to $67.8 Million
Record Quarterly Net Income of $12.4 Million
Proto Labs, Inc. (NYSE:PRLB), a leading online and technology-enabled,
quick-turn, on-demand manufacturer, today announced financial results
for the third quarter ended September 30, 2015.
Highlights include:
-
Revenue for the third quarter of 2015 increased to a record $67.8
million, 24 percent above revenue of $54.6 million in the third
quarter of 2014. On a constant currency basis, revenue was up 28
percent versus the prior year.
-
Revenue from additive services (3D printing) totaled $6.0 million, an
increase of 79 percent from the third quarter of 2014.
-
Revenue growth reflected a 24 percent increase in the number of unique
product developers and engineers served over the prior year period.
-
Net income for the third quarter of 2015 was a record $12.4 million,
or $0.47 per diluted share. Non-GAAP net income, excluding the
after-tax expense of stock compensation, transaction costs related to
the Alphaform acquisition, amortization of intangibles and unrealized
foreign currency gains, was $13.7 million, or $0.52 per diluted share.
See “Non-GAAP Financial Measures” below.
“We continued to demonstrate strong momentum in the third quarter,
reflecting solid execution of our marketing and sales, manufacturing,
and new product and service initiatives,” said Vicki Holt, President and
Chief Executive Officer. “Revenue in North America increased 26%
percent, led by strong growth in additive manufacturing and Firstcut
services. Europe remained a highlight with 40 percent revenue growth on
a constant currency basis, 21 percent when translated to dollars. Japan
generated a 33 percent increase in revenue on a constant currency basis,
14 percent as reported.”
Additional Third Quarter Highlights include:
-
Gross margin was 59.4 percent of revenue for the third quarter of 2015
compared with 58.7 percent for the second quarter of 2015 and 60.6
percent during the same quarter last year.
-
GAAP operating margin, including transaction expenses, was 25.7
percent of revenue during the third quarter of 2015 compared to 28.3
percent for the third quarter of 2014. On a non-GAAP basis, operating
margins were 29.3 percent. See “Non-GAAP Financial Measures” below.
-
Cash generated from operations during the third quarter totaled $13.5
million. Cash, cash equivalents and investments were $150.0 million at
September 30, 2015 compared with $142.0 million at June 30, 2015.
“On October 9, we announced the completion of our acquisition of
Alphaform, a leading service bureau based in Germany,” Ms. Holt
continued. “We are very excited about the opportunities this transaction
offers Proto Labs. Alphaform is known for its quality additive
manufacturing and injection molding services and we expect this
acquisition will significantly accelerate our growth in Europe. We
believe we can leverage Alphaform’s manufacturing assets, customer base
and experienced workforce quickly and cost effectively into our existing
European operations, positioning us well for future expansion.”
“We are on track with the roll out of our new materials and service
offerings. Demand for our Stereolithography service in Europe, launched
in the second quarter, has been growing steadily. We are seeing
excellent reception for our lathe process which is now operational in
all of our regions. We remain focused on our marketing and sales
initiatives and we are gaining traction in markets worldwide. We look
forward to the opportunities ahead and are working very hard to execute
on our strategy for growth,” concluded Ms. Holt.
Non-GAAP Financial Measures
The company has included non-GAAP adjusted revenue growth that excludes
the impact of changes in foreign currency exchange rates from total
revenues in this press release to provide investors with additional
information regarding the company’s financial results. Management
believes this metric is useful in evaluating the underlying business
trends and ongoing operating performance of the company.
The company has also included non-GAAP operating margin, adjusted for
stock-based compensation expense, transaction expenses related to the
acquisition of Alphaform and amortization expense in this press release
to provide investors with additional information regarding the company’s
financial results.
The company has also included non-GAAP net income, adjusted for
stock-based compensation expense, transaction expenses related to the
acquisition of Alphaform, amortization expense, and unrealized foreign
currency activity (collectively, “non-GAAP net income”), in this press
release to provide investors with additional information regarding the
company’s financial results.
The company has provided below a reconciliation of non-GAAP operating
margin to operating margin and non-GAAP net income to net income, the
most directly comparable measures calculated and presented in accordance
with GAAP. Non-GAAP operating margins and non-GAAP net income are used
by the company’s management and board of directors to understand and
evaluate operating performance and trends and provide useful measures
for period-to-period comparisons of the company’s business. Accordingly,
the company believes that non-GAAP operating margin and net income
provide useful information to investors and others in understanding and
evaluating operating results in the same manner as our management and
board of directors.
Conference Call
The company has scheduled a conference call to discuss its third quarter
financial results today, October 22, 2015 at 8:30 a.m. ET. To access the
call in the U.S. please dial 877-709-8150. Outside the U.S. please dial
201-689-8354. No participant code is required. A simultaneous webcast of
the call will be available via the investor relations section of the
Proto Labs website and the following link: http://edge.media-server.com/m/p/rjdabigy/lan/en.
An audio replay will be available for 14 days following the call on the
investor relations section of Proto Labs’ website.
About Proto Labs, Inc.
Proto Labs is the world’s fastest digital manufacturing source for
custom prototypes and low-volume production parts. The
technology-enabled company uses advanced 3D printing, CNC machining and
injection molding technologies to produce parts within days. The result
is an unprecedented speed-to-market value for product designers and
engineers worldwide. Visit protolabs.com for more information.
Forward-Looking Statements
Statements contained in this press release regarding matters that are
not historical or current facts are “forward-looking statements” within
the meaning of The Private Securities Litigation Reform Act of 1995.
These statements involve known and unknown risks, uncertainties and
other factors which may cause the results of Proto Labs to be materially
different than those expressed or implied in such statements. Certain of
these risk factors and others are described in the “Risk Factors”
section within reports filed with the SEC. Other unknown or
unpredictable factors also could have material adverse effects on Proto
Labs’ future results. The forward-looking statements included in this
press release are made only as of the date hereof. Proto Labs cannot
guarantee future results, levels of activity, performance or
achievements. Accordingly, you should not place undue reliance on these
forward-looking statements. Finally, Proto Labs expressly disclaims any
intent or obligation to update any forward-looking statements to reflect
subsequent events or circumstances.
|
Proto Labs, Inc.
|
Condensed Consolidated Balance Sheets
|
(In thousands)
|
|
|
|
|
|
|
|
|
|
|
|
September 30,
|
|
|
December 31,
|
|
|
|
2015
|
|
|
2014
|
|
|
|
(Unaudited)
|
|
|
|
Assets
|
|
|
|
|
|
|
Current assets
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
|
$
|
64,131
|
|
|
$
|
43,329
|
Short-term marketable securities
|
|
|
|
28,062
|
|
|
|
30,706
|
Accounts receivable, net
|
|
|
|
32,897
|
|
|
|
24,226
|
Inventory
|
|
|
|
7,228
|
|
|
|
6,194
|
Income taxes receivable
|
|
|
|
4,029
|
|
|
|
-
|
Other current assets
|
|
|
|
6,193
|
|
|
|
3,889
|
Total current assets
|
|
|
|
142,540
|
|
|
|
108,344
|
|
|
|
|
|
|
|
Property and equipment, net
|
|
|
|
108,626
|
|
|
|
91,626
|
Long-term marketable securities
|
|
|
|
57,801
|
|
|
|
54,318
|
Goodwill
|
|
|
|
28,916
|
|
|
|
28,916
|
Other intangible assets, net
|
|
|
|
3,523
|
|
|
|
4,083
|
Other long-term assets
|
|
|
|
520
|
|
|
|
227
|
Total assets
|
|
|
$
|
341,926
|
|
|
$
|
287,514
|
|
|
|
|
|
|
|
Liabilities and shareholders' equity
|
|
|
|
|
|
|
Current liabilities
|
|
|
|
|
|
|
Accounts payable
|
|
|
$
|
11,552
|
|
|
$
|
7,882
|
Accrued compensation
|
|
|
|
10,519
|
|
|
|
6,067
|
Accrued liabilities and other
|
|
|
|
2,424
|
|
|
|
2,718
|
Income taxes payable
|
|
|
|
-
|
|
|
|
1,953
|
Current portion of long-term debt obligations
|
|
|
|
39
|
|
|
|
139
|
Total current liabilities
|
|
|
|
24,534
|
|
|
|
18,759
|
|
|
|
|
|
|
|
Long-term deferred tax liabilities
|
|
|
|
1,488
|
|
|
|
1,846
|
Long-term debt obligations
|
|
|
|
-
|
|
|
|
10
|
Other long-term liabilities
|
|
|
|
1,716
|
|
|
|
1,360
|
|
|
|
|
|
|
|
Shareholders' equity
|
|
|
|
314,188
|
|
|
|
265,539
|
Total liabilities and shareholders' equity
|
|
|
$
|
341,926
|
|
|
$
|
287,514
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proto Labs, Inc.
|
Condensed Consolidated Statements of Operations
|
(In thousands, except share and per share amounts)
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
Nine Months Ended
|
|
|
|
September 30,
|
|
|
September 30,
|
|
|
|
2015
|
|
|
2014
|
|
|
2015
|
|
|
2014
|
Revenue
|
|
|
|
|
|
|
|
|
|
|
|
|
Protomold
|
|
|
$
|
41,971
|
|
|
$
|
35,655
|
|
|
|
$
|
119,521
|
|
|
$
|
104,604
|
|
Firstcut
|
|
|
|
19,833
|
|
|
|
15,549
|
|
|
|
|
54,788
|
|
|
|
43,407
|
|
Fineline
|
|
|
|
6,038
|
|
|
|
3,370
|
|
|
|
|
16,038
|
|
|
|
5,503
|
|
Total revenue
|
|
|
|
67,842
|
|
|
|
54,574
|
|
|
|
|
190,347
|
|
|
|
153,514
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of revenue
|
|
|
|
27,517
|
|
|
|
21,492
|
|
|
|
|
77,218
|
|
|
|
58,725
|
|
Gross profit
|
|
|
|
40,325
|
|
|
|
33,082
|
|
|
|
|
113,129
|
|
|
|
94,789
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
Marketing and sales
|
|
|
|
10,027
|
|
|
|
7,351
|
|
|
|
|
28,383
|
|
|
|
21,029
|
|
Research and development
|
|
|
|
4,760
|
|
|
|
4,555
|
|
|
|
|
13,471
|
|
|
|
11,925
|
|
General and administrative
|
|
|
|
8,134
|
|
|
|
5,733
|
|
|
|
|
20,683
|
|
|
|
15,970
|
|
Total operating expenses
|
|
|
|
22,921
|
|
|
|
17,639
|
|
|
|
|
62,537
|
|
|
|
48,924
|
|
Income from operations
|
|
|
|
17,404
|
|
|
|
15,443
|
|
|
|
|
50,592
|
|
|
|
45,865
|
|
Other income (expense), net
|
|
|
|
593
|
|
|
|
(56
|
)
|
|
|
|
100
|
|
|
|
(19
|
)
|
Income before income taxes
|
|
|
|
17,997
|
|
|
|
15,387
|
|
|
|
|
50,692
|
|
|
|
45,846
|
|
Provision for income taxes
|
|
|
|
5,615
|
|
|
|
5,003
|
|
|
|
|
16,171
|
|
|
|
14,404
|
|
Net income
|
|
|
$
|
12,382
|
|
|
$
|
10,384
|
|
|
|
$
|
34,521
|
|
|
$
|
31,442
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
$
|
0.47
|
|
|
$
|
0.40
|
|
|
|
$
|
1.33
|
|
|
$
|
1.23
|
|
Diluted
|
|
|
$
|
0.47
|
|
|
$
|
0.40
|
|
|
|
$
|
1.31
|
|
|
$
|
1.20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares used to compute net income per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
|
26,083,405
|
|
|
|
25,757,593
|
|
|
|
|
25,952,451
|
|
|
|
25,651,156
|
|
Diluted
|
|
|
|
26,381,313
|
|
|
|
26,200,741
|
|
|
|
|
26,290,758
|
|
|
|
26,109,539
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proto Labs, Inc.
|
Condensed Consolidated Statements of Cash Flows
|
(In thousands)
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended
|
|
|
|
September 30,
|
|
|
|
2015
|
|
|
2014
|
Operating activities
|
|
|
|
|
|
|
Net income
|
|
|
$
|
34,521
|
|
|
|
$
|
31,442
|
|
Adjustments to reconcile net income to net cash provided by
operating activities:
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
|
10,422
|
|
|
|
|
7,696
|
|
Stock-based compensation expense
|
|
|
|
4,515
|
|
|
|
|
3,561
|
|
Deferred taxes
|
|
|
|
(310
|
)
|
|
|
|
487
|
|
Excess tax benefit from stock-based compensation
|
|
|
|
(5,212
|
)
|
|
|
|
(4,383
|
)
|
Amortization of held-to-maturity securities
|
|
|
|
936
|
|
|
|
|
1,194
|
|
Changes in operating assets and liabilities
|
|
|
|
(3,588
|
)
|
|
|
|
7
|
|
Net cash provided by operating activities
|
|
|
|
41,284
|
|
|
|
|
40,004
|
|
|
|
|
|
|
|
|
Investing activities
|
|
|
|
|
|
|
Purchases of property and equipment
|
|
|
|
(27,259
|
)
|
|
|
|
(35,928
|
)
|
Acquisitions, net of cash acquired
|
|
|
|
-
|
|
|
|
|
(33,864
|
)
|
Purchases of marketable securities
|
|
|
|
(42,674
|
)
|
|
|
|
(47,338
|
)
|
Proceeds from sales and maturities of marketable securities
|
|
|
|
40,899
|
|
|
|
|
61,896
|
|
Net cash used in investing activities
|
|
|
|
(29,034
|
)
|
|
|
|
(55,234
|
)
|
|
|
|
|
|
|
|
Financing activities
|
|
|
|
|
|
|
Payments on debt
|
|
|
|
(107
|
)
|
|
|
|
(1,005
|
)
|
Acquisition-related contingent consideration
|
|
|
|
(1,400
|
)
|
|
|
|
(800
|
)
|
Proceeds from exercises of stock options and other
|
|
|
|
5,165
|
|
|
|
|
3,962
|
|
Excess tax benefit from stock-based compensation
|
|
|
|
5,212
|
|
|
|
|
4,383
|
|
Net cash provided by financing activities
|
|
|
|
8,870
|
|
|
|
|
6,540
|
|
Effect of exchange rate changes on cash and cash equivalents
|
|
|
|
(318
|
)
|
|
|
|
(81
|
)
|
Net increase (decrease) in cash and cash equivalents
|
|
|
|
20,802
|
|
|
|
|
(8,771
|
)
|
Cash and cash equivalents, beginning of period
|
|
|
|
43,329
|
|
|
|
|
43,039
|
|
Cash and cash equivalents, end of period
|
|
|
$
|
64,131
|
|
|
|
$
|
34,268
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proto Labs, Inc.
|
Reconciliation of GAAP to Non-GAAP Net Income per Share
|
(In thousands, except share and per share amounts)
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
Nine Months Ended
|
|
|
|
September 30,
|
|
|
September 30,
|
|
|
|
2015
|
|
|
2014
|
|
|
2015
|
|
|
2014
|
Non-GAAP net income, adjusted for stock-based compensation
expense, amortization expense, unrealized loss (gain) on foreign
currency, and acquisition costs:
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP net income
|
|
|
$
|
12,382
|
|
|
|
$
|
10,384
|
|
|
|
$
|
34,521
|
|
|
|
$
|
31,442
|
|
Add back:
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation expense
|
|
|
|
1,606
|
|
|
|
|
1,313
|
|
|
|
|
4,515
|
|
|
|
|
3,561
|
|
Income tax benefits on stock-based compensation expense
|
|
|
|
(494
|
)
|
|
|
|
(417
|
)
|
|
|
|
(1,378
|
)
|
|
|
|
(1,128
|
)
|
Amortization expense
|
|
|
|
186
|
|
|
|
|
186
|
|
|
|
|
559
|
|
|
|
|
311
|
|
Income tax benefits on amortization expense
|
|
|
|
(65
|
)
|
|
|
|
(65
|
)
|
|
|
|
(196
|
)
|
|
|
|
(109
|
)
|
Unrealized loss (gain) on foreign currency
|
|
|
|
(407
|
)
|
|
|
|
104
|
|
|
|
|
211
|
|
|
|
|
231
|
|
Income tax benefits on unrealized loss (gain) on foreign currency
|
|
|
|
78
|
|
|
|
|
(26
|
)
|
|
|
|
(50
|
)
|
|
|
|
(47
|
)
|
Acquisition costs
|
|
|
|
648
|
|
|
|
|
-
|
|
|
|
|
648
|
|
|
|
|
-
|
|
Income tax benefits on acquisition costs
|
|
|
|
(227
|
)
|
|
|
|
-
|
|
|
|
|
(227
|
)
|
|
|
|
-
|
|
Total adjustments
|
|
|
|
1,325
|
|
|
|
|
1,095
|
|
|
|
|
4,082
|
|
|
|
|
2,819
|
|
Non-GAAP net income adjusted for stock-based compensation expense,
amortization expense, unrealized loss (gain) on foreign currency,
and acquisition costs
|
|
|
$
|
13,707
|
|
|
|
$
|
11,479
|
|
|
|
$
|
38,603
|
|
|
|
$
|
34,261
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP net income per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
$
|
0.53
|
|
|
|
$
|
0.45
|
|
|
|
$
|
1.49
|
|
|
|
$
|
1.34
|
|
Diluted
|
|
|
$
|
0.52
|
|
|
|
$
|
0.44
|
|
|
|
$
|
1.47
|
|
|
|
$
|
1.31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares used to compute non-GAAP net income per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
|
26,083,405
|
|
|
|
|
25,757,593
|
|
|
|
|
25,952,451
|
|
|
|
|
25,651,156
|
|
Diluted
|
|
|
|
26,381,313
|
|
|
|
|
26,200,741
|
|
|
|
|
26,290,758
|
|
|
|
|
26,109,539
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proto Labs, Inc.
|
Reconciliation of GAAP to Non-GAAP Operating Margin
|
(In thousands)
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
Nine Months Ended
|
|
|
|
September 30,
|
|
|
September 30,
|
|
|
|
2015
|
|
|
2014
|
|
|
2015
|
|
|
2014
|
Revenue
|
|
|
$
|
67,842
|
|
|
|
$
|
54,574
|
|
|
|
$
|
190,347
|
|
|
|
$
|
153,514
|
|
Income from operations
|
|
|
|
17,404
|
|
|
|
|
15,443
|
|
|
|
|
50,592
|
|
|
|
|
45,865
|
|
GAAP operating margin
|
|
|
|
25.7
|
%
|
|
|
|
28.3
|
%
|
|
|
|
26.6
|
%
|
|
|
|
29.9
|
%
|
Add back:
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation expense
|
|
|
|
1,606
|
|
|
|
|
1,313
|
|
|
|
|
4,515
|
|
|
|
|
3,561
|
|
Amortization expense
|
|
|
|
186
|
|
|
|
|
186
|
|
|
|
|
559
|
|
|
|
|
311
|
|
Acquisition costs
|
|
|
|
648
|
|
|
|
|
-
|
|
|
|
|
648
|
|
|
|
|
-
|
|
Total adjustments
|
|
|
|
2,440
|
|
|
|
|
1,499
|
|
|
|
|
5,722
|
|
|
|
|
3,872
|
|
Non-GAAP income from operations adjusted for stock-based
compensation expense, amortization expense and acquisition costs
|
|
|
$
|
19,844
|
|
|
|
$
|
16,942
|
|
|
|
$
|
56,314
|
|
|
|
$
|
49,737
|
|
Non-GAAP operating margin
|
|
|
|
29.3
|
%
|
|
|
|
31.0
|
%
|
|
|
|
29.6
|
%
|
|
|
|
32.4
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proto Labs, Inc.
|
Comparison of GAAP to Non-GAAP Revenue Growth
|
(In thousands)
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
|
|
% Change
|
|
|
Nine Months Ended
|
|
|
|
|
|
% Change
|
|
|
|
September 30,
|
|
|
%
|
|
|
Constant
|
|
|
September 30,
|
|
|
%
|
|
|
Constant
|
|
|
|
2015
|
|
|
2014
|
|
|
Change
|
|
|
Currencies1
|
|
|
2015
|
|
|
2014
|
|
|
Change
|
|
|
Currencies1
|
Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States
|
|
|
$
|
54,408
|
|
|
$
|
43,363
|
|
|
25.5
|
%
|
|
|
25.5
|
%
|
|
|
$
|
154,107
|
|
|
$
|
120,781
|
|
|
27.6
|
%
|
|
|
27.6
|
%
|
Europe
|
|
|
|
11,297
|
|
|
|
9,333
|
|
|
21.0
|
%
|
|
|
39.9
|
%
|
|
|
|
30,161
|
|
|
|
27,523
|
|
|
9.6
|
%
|
|
|
27.9
|
%
|
Japan
|
|
|
|
2,137
|
|
|
|
1,878
|
|
|
13.8
|
%
|
|
|
33.4
|
%
|
|
|
|
6,079
|
|
|
|
5,210
|
|
|
16.7
|
%
|
|
|
36.9
|
%
|
Total Revenue
|
|
|
$
|
67,842
|
|
|
$
|
54,574
|
|
|
24.3
|
%
|
|
|
28.2
|
%
|
|
|
$
|
190,347
|
|
|
$
|
153,514
|
|
|
24.0
|
%
|
|
|
28.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 Revenue growth for the three- and nine-month periods
ended September 30, 2015 has been recalculated using 2014 foreign
currency exchange rates in effect during comparable periods to
provide information useful in evaluating the underlying business
trends excluding the impact of changes in foreign currency exchange
rates.
|
|
|
Proto Labs, Inc.
|
Revenue by Geography - Based on Shipping Location
|
(In thousands)
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
Nine Months Ended
|
|
|
|
September 30,
|
|
|
September 30,
|
|
|
|
2015
|
|
|
2014
|
|
|
2015
|
|
|
2014
|
Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
Domestic
|
|
|
|
|
|
|
|
|
|
|
|
|
United States
|
|
|
$
|
50,214
|
|
|
$
|
40,822
|
|
|
$
|
144,356
|
|
|
$
|
113,810
|
International
|
|
|
|
|
|
|
|
|
|
|
|
|
Europe
|
|
|
|
11,297
|
|
|
|
9,333
|
|
|
|
30,161
|
|
|
|
27,523
|
Japan
|
|
|
|
2,137
|
|
|
|
1,878
|
|
|
|
6,079
|
|
|
|
5,210
|
United States
|
|
|
|
4,194
|
|
|
|
2,541
|
|
|
|
9,751
|
|
|
|
6,971
|
Total international
|
|
|
|
17,628
|
|
|
|
13,752
|
|
|
|
45,991
|
|
|
|
39,704
|
Total revenue
|
|
|
$
|
67,842
|
|
|
$
|
54,574
|
|
|
$
|
190,347
|
|
|
$
|
153,514
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proto Labs, Inc.
|
Product Developer Information
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
Nine Months Ended
|
|
|
|
September 30,
|
|
|
September 30,
|
|
|
|
2015
|
|
|
2014
|
|
|
2015
|
|
|
2014
|
Unique product developers and engineers served
|
|
|
12,541
|
|
|
10,097
|
|
|
22,633
|
|
|
17,526
|
|
|
|
|
|
|
|
|
|
|
|
|
|
View source version on businesswire.com: http://www.businesswire.com/news/home/20151022005304/en/
Copyright Business Wire 2015